Logo

Rubicon to Help Genome Institute of Singapore in Hep B Vaccine Research

Jul 21, 2005

NEW YORK, July 21 (GenomeWeb News) - Rubicon Genomics will extract small amounts of DNA from archived serum samples for the Genome Institute of Singapore, the Ann Arbor, Mich.-based company said today.

 

Under the agreement, Rubicon will isolate and amplify genomic DNA from 5,000 serum samples from a hepatitis B vaccine trial using its technology, which enables researchers to purify DNA from as few as 10 cells.

 

GIS plans to use the DNA in an international study with researchers in Indonesiaand the Netherlandsto discover genes important for hepatitis B prevention and treatment.

Breaking News
The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.